SLC30A7 — Solute Carrier Family 30 Member 7 (SLC30A7)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC30A7 — Solute Carrier Family 30 Member 7</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>SLC30A7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 30 Member 7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p21.2</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Zinc transporter (ZnT7)</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Trans-Golgi network, secretory vesicles</td>
</tr>
</table>
Overview
SLC30A7 encodes zinc transporter 7 (ZnT7), a membrane protein belonging to the solute carrier family 30 of zinc transporters. This gene is located on chromosome 1p21.2 and encodes a protein that facilitates zinc efflux from the cytoplasm into intracellular compartments, particularly the trans-Golgi network and secretory vesicles. Zinc homeostasis is critically important for neuronal function, synaptic transmission, and protection against oxidative stress. Dysregulation of zinc transport mechanisms, including SLC30A7 dysfunction, has emerged as a significant factor in various neurodegenerative diseases.
Function/Biology
...SLC30A7 — Solute Carrier Family 30 Member 7 (SLC30A7)
<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">SLC30A7 — Solute Carrier Family 30 Member 7</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td>SLC30A7</td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Solute Carrier Family 30 Member 7</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>1p21.2</td>
</tr>
<tr>
<td class="label">Protein Class</td>
<td>Zinc transporter (ZnT7)</td>
</tr>
<tr>
<td class="label">Cellular Localization</td>
<td>Trans-Golgi network, secretory vesicles</td>
</tr>
</table>
Overview
SLC30A7 encodes zinc transporter 7 (ZnT7), a membrane protein belonging to the solute carrier family 30 of zinc transporters. This gene is located on chromosome 1p21.2 and encodes a protein that facilitates zinc efflux from the cytoplasm into intracellular compartments, particularly the trans-Golgi network and secretory vesicles. Zinc homeostasis is critically important for neuronal function, synaptic transmission, and protection against oxidative stress. Dysregulation of zinc transport mechanisms, including SLC30A7 dysfunction, has emerged as a significant factor in various neurodegenerative diseases.
Function/Biology
ZnT7, the protein product of SLC30A7, functions as a cation/proton antiporter that pumps zinc ions into acidified intracellular organelles. This transporter is predominantly expressed in the secretory pathway and plays a crucial role in loading zinc into secretory vesicles destined for release into the extracellular space. Unlike other ZnT family members that primarily localize to the plasma membrane, ZnT7 is uniquely positioned within the Golgi apparatus and associated vesicles.
The transporter contains eight transmembrane domains with characteristic metal-binding histidine-rich domains in the cytoplasmic loops. These domains recognize and bind zinc ions, facilitating their transport across vesicular membranes. ZnT7 activity is essential for maintaining appropriate zinc concentrations in secretory compartments, which impacts the zinc content of secreted proteins and extracellular signaling molecules.
Role in Neurodegeneration
Zinc dysregulation represents an increasingly recognized contributor to neurodegeneration. SLC30A7 dysfunction leads to altered zinc distribution within neurons, affecting multiple pathological processes. Impaired zinc transport into the secretory pathway can compromise the zinc-loading of neuropeptides, growth factors, and other zinc-dependent secreted proteins critical for neuronal survival and synaptic plasticity.
Aberrant zinc homeostasis amplifies oxidative stress, enhances protein aggregation, and promotes neuroinflammation—hallmark features of neurodegenerative diseases. In Alzheimer's disease, dysregulated zinc accumulation at amyloid-beta plaques and impaired zinc transport contribute to neuronal dysfunction. SLC30A7 dysfunction may exacerbate these pathologies by reducing neuroprotective zinc-dependent mechanisms while permitting cytoplasmic zinc accumulation.
Molecular Mechanisms
The molecular pathology of SLC30A7 in neurodegeneration operates through several interconnected mechanisms:
Zinc Trafficking Defects: Loss of SLC30A7 function impairs zinc sequestration into the secretory pathway, causing cytoplasmic zinc accumulation that triggers oxidative stress through excessive reactive oxygen species generation.
Protein Aggregation: Zinc is essential for proper protein folding through metalloproteins like zinc-finger domains. Aberrant zinc distribution promotes misfolding of tau, alpha-synuclein, and other aggregation-prone proteins.
Mitochondrial Dysfunction: Improper zinc homeostasis compromises mitochondrial function, reducing ATP production and amplifying bioenergetic stress in neurons.
Synaptic Transmission Impairment: Vesicular zinc is co-released with glutamate from presynaptic terminals and regulates postsynaptic receptor function. SLC30A7 dysfunction disrupts this zinc-dependent synaptic signaling.
Clinical/Research Significance
SLC30A7 variants have been associated with familial and sporadic neurodegenerative conditions, though comprehensive clinical characterization remains incomplete. Research indicates SLC30A7 expression changes in Alzheimer's disease post-mortem brain tissue. The transporter represents a potential therapeutic target, as modulating SLC30A7 activity could normalize zinc distribution and reduce neurodegeneration-associated pathology.
Current research efforts focus on identifying disease